Obstetrics & Gynecology Science

Gynecologic Oncology
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer: Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy; Obstet Gynecol Sci. 2020;63(5):643-654. Published online September 2, 2020; DOI: https://doi.org/10.5468/ogs.20033
Web of Science 4 Crossref 4; Full text PubReader ePub PDF

Germline PALB2, ATM variants in a patient with breast and ovarian cancer at risk for familial cancer syndrome: Is there a role for risk-reducing salpingo-oophorectomy?: Semiramis L. Carbajal-Mamani, Merry J. Markham, Joaquín Santolaya-Forgas, Jacqueline C. Castagno, Joel Cardenas-Goicoechea; Obstet Gynecol Sci. 2020;63(2):205-208. Published online February 5, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.2.205; Full text PubReader ePub PDF

Immunohisochemical study of BRCA1, BRCA2, and poly (ADP-ribose) polymerase-1 in ovarian tumors.: Se Kyung Choi, Tae Il Cho, Tae Jin Lee; Korean J Obstet Gynecol. 2012;55(1):8-16. Published online January 1, 2012; DOI: https://doi.org/10.5468/KJOG.2012.55.1.8; PDF

Germline Mutations and polymorphisms of BRCA1 and BRCA2 in Sporadic Ovarian Carcinoma.: Eun Ji Nam, Young Tae Kim, Sung Hoon Kim, Jae Hoon Kim, Ja Seong Koo, Sang Woon Kim, Jae Wook Kim, Hyun Ki Kim; Korean J Obstet Gynecol. 2005;48(6):1466-1475. Published online June 1, 2005

Search